Sanofi
Latest statistics and disclosures from Sanofi's latest quarterly 13F-HR filing:
- Top 5 stock holdings are MGTX, INBX, NVAX, ANAB, Odyssey Therapeutics, and represent 80.91% of Sanofi's stock portfolio.
- Added to shares of these 2 stocks: Odyssey Therapeutics (+$37M), TRAX (+$17M).
- Started 2 new stock positions in Odyssey Therapeutics, TRAX.
- Reduced shares in these 1 stock: ELDN.
- Sold out of its position in ELDN.
- Sanofi was a net buyer of stock by $51M.
- Sanofi has $534M in assets under management (AUM), dropping by 58.96%.
- Central Index Key (CIK): 0001121404
Tip: Access up to 7 years of quarterly data
Positions held by Sanofi consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Sanofi
Sanofi holds 10 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Meiragtx Holdings (MGTX) | 30.9 | $165M | 12M | 13.51 |
|
|
| Inhibrx Biosciences (INBX) | 20.5 | $110M | 1.2M | 94.75 |
|
|
| Novavax Com New (NVAX) | 12.1 | $65M | 6.9M | 9.42 |
|
|
| Anaptysbio Inc Common (ANAB) | 10.4 | $56M | 822k | 67.50 |
|
|
| Odyssey Therapeutics Common Stock | 7.0 | $37M | NEW | 2.0M | 18.71 |
|
| Agomab Therapeutics NV Sponsored Ads (AGMB) | 6.8 | $36M | 2.8M | 12.98 |
|
|
| Maplight Therapeutics (MPLT) | 6.1 | $33M | 912k | 35.84 |
|
|
| First Tracks Biotherapeutics Ord Shs (TRAX) | 3.1 | $17M | NEW | 822k | 20.12 |
|
| Immuneering Corp Class A Com (IMRX) | 2.5 | $14M | 2.7M | 4.99 |
|
|
| Q32 Bio (QTTB) | 0.6 | $3.1M | 244k | 12.74 |
|
Past Filings by Sanofi
SEC 13F filings are viewable for Sanofi going back to 2025
- Sanofi 2026 Q2 filed July 28, 2026
- Sanofi 2026 Q1 filed May 7, 2026
- Sanofi 2025 Q4 filed Feb. 11, 2026
- Sanofi 2025 Q3 filed Nov. 4, 2025
- Sanofi 2025 Q2 filed July 29, 2025